1. Home
  2. MYSZ vs VRAX Comparison

MYSZ vs VRAX Comparison

Compare MYSZ & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo My Size Inc.

MYSZ

My Size Inc.

N/A

Current Price

$0.86

Market Cap

869.6K

Sector

Technology

ML Signal

N/A

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

N/A

Current Price

$1.17

Market Cap

972.3K

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYSZ
VRAX
Founded
1999
2013
Country
Israel
United Kingdom
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
869.6K
972.3K
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
MYSZ
VRAX
Price
$0.86
$1.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
79.3K
★ 152.5K
Earning Date
11-13-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 57.40
N/A
EPS
N/A
★ N/A
Revenue
★ $142,000.00
N/A
Revenue This Year
$38.86
N/A
Revenue Next Year
$9.69
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 125.40
N/A
52 Week Low
$0.37
$0.10
52 Week High
$292.78
$13.19

Technical Indicators

Market Signals
Indicator
MYSZ
VRAX
Relative Strength Index (RSI) 23.94 27.04
Support Level $0.37 $0.15
Resistance Level $2.60 $2.92
Average True Range (ATR) 0.11 0.14
MACD 0.17 0.01
Stochastic Oscillator 2.61 7.46

Price Performance

Historical Comparison
MYSZ
VRAX

About MYSZ My Size Inc.

My Size Inc is a fashion technology company operating an integrated portfolio of businesses designed to address the pressing challenges facing fashion brands and retailers today - size and fit accuracy, excess inventory management, circular economy solutions, and international market distribution. The company, through its subsidaries provide end-to-end support across the fashion value chain; delivers AI-driven size and fit solutions for fashion e-commerce companies. The firm has the following four segments: (i) Fashion e-commerce platform, (ii) SaaS solutions, (iii) resale platform for apparel, and (iv) wholesaling of footwear. The company generates the majority of its revenue from the fashion e-commerce platform segment.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

Share on Social Networks: